New data from a long-term extension study demonstrates sustained improvements in wakefulness, cognition, and fatigue for adults with narcolepsy type 1 and type 2.

Incannex Healthcare has initiated screening for its DReAMzz dose confirmation study evaluating IHL-42X for obstructive sleep apnea.

On July 14, the Centers for Medicare & Medicaid Services (CMS) released the 2027 physician fee schedule (PFS) proposed rule. The proposal includes payment updates, telehealth policies, and several initiatives that co...

On July 12, Pennsylvania Governor Josh Shapiro signed into law HB 1505, a state budget package, which included a provision permitting school districts to redirect existing funding streams, to cover the costs of planning,...

The oral orexin 2 receptor agonist currently in phase 1b development for patients with narcolepsy.

The agency cited unapproved modifications to the an auto-CPAP system imported into the United States and a failure to report a firmware correction for unexpected shutdowns.

A neuroscientist breaks down a common misconception about a rare sleep disorder.

Innovations in home sleep testing, CPAP therapy, and EEG were recognized for their design and usability in the international competition.

A study suggests snoring is not just a symptom of OSA but may actively contribute to the sleep disorder.

Researchers at the University of Texas at Austin have developed a noninvasive, wearable ultrasound patch that helps users reach REM sleep faster and maintain it longer. The NEUSLeeP device, which simultaneously monitors...